Gut Microbiota Alter Colonic Expression of Genes Encoding Drug Transporters and Drug-Metabolizing Enzymes in Mice
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177583 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Douglas A Nelson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Brain Barriers Research Center, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Colon, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NINDS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Gut microbiota regulate the intestinal expression of drug-metabolizing enzymes, transporters, and barrier properties that determine oral drug absorption and disposition. This study compares germ-free Swiss Webster mice to mice colonized with fecal microbiota from a single human donor, evaluating microbiota-driven differences in colonic gene expression and P-gp protein expression, as well as small intestinal mucosal permeability. Transcriptomic analysis of colonic tissue revealed microbiota-induced upregulation of genes encoding P-gp and other drug transporters, including MCT1 and OCTN2. Immunofluorescence also indicated greater P-gp expression and apical localization in colonized mice. Gene expression of drug-metabolizing enzymes was also higher in colonized mice, including phase I enzymes (carboxylesterase 2 paralogs), phase II enzymes (UDP-glucuronosyltransferases and glutathione S-transferases), and enzymes responsible for synthesizing their co-substrates, UDP-glucuronic acid and glutathione. Small intestinal mucosal explants demonstrated lower permeability to 14C-labeled polyethylene glycol 4000 in colonized mice compared to germ-free mice. In the colon, transcriptomic analysis identified microbiota-dependent changes in genes regulating paracellular tight junctions and actomyosin contractility. These results show that human-derived gut microbiota alter gene expression in the mouse colon, identifying candidate microbiota-responsive genes relevant to oral drug absorption and disposition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Brain Barriers Research Center, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
- Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Karunya K Kandimalla
Förderung
- NIDDK NIH HHS
- NINDS NIH HHS
- NIA NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Nelson, D. A., Veerareddy, V., Tang, X., Kashyap, P. C., Kalari, K. R., & Kandimalla, K. K. (2026). Gut Microbiota Alter Colonic Expression of Genes Encoding Drug Transporters and Drug-Metabolizing Enzymes in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177583
Vancouver
Nelson DA, Veerareddy V, Tang X, Kashyap PC, Kalari KR, Kandimalla KK. Gut Microbiota Alter Colonic Expression of Genes Encoding Drug Transporters and Drug-Metabolizing Enzymes in Mice. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177583
BibTeX
@article{Nelson2026,
author = {Nelson, Douglas A and Veerareddy, Vaishnavi and Tang, Xiaojia and Kashyap, Purna C and Kalari, Krishna R and Kandimalla, Karunya K},
title = {Gut Microbiota Alter Colonic Expression of Genes Encoding Drug Transporters and Drug-Metabolizing Enzymes in Mice},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177583}
}
EUVIMED